JP2022543722A5 - - Google Patents
Info
- Publication number
- JP2022543722A5 JP2022543722A5 JP2021554990A JP2021554990A JP2022543722A5 JP 2022543722 A5 JP2022543722 A5 JP 2022543722A5 JP 2021554990 A JP2021554990 A JP 2021554990A JP 2021554990 A JP2021554990 A JP 2021554990A JP 2022543722 A5 JP2022543722 A5 JP 2022543722A5
- Authority
- JP
- Japan
- Prior art keywords
- ptbp1
- rna
- gene editing
- group
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910760367 | 2019-08-16 | ||
| CN201910760367.6 | 2019-08-16 | ||
| CN201911046435.9 | 2019-10-30 | ||
| CN201911046435 | 2019-10-30 | ||
| PCT/CN2020/081489 WO2021031565A1 (en) | 2019-08-16 | 2020-03-26 | Treatment of Neuronal Diseases |
| CNPCT/CN2020/081489 | 2020-03-26 | ||
| CN202010740568.2A CN112451669A (zh) | 2019-08-16 | 2020-07-28 | Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用 |
| CN202010740568.2 | 2020-07-28 | ||
| PCT/CN2020/109653 WO2021032068A1 (zh) | 2019-08-16 | 2020-08-17 | Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543722A JP2022543722A (ja) | 2022-10-14 |
| JP2022543722A5 true JP2022543722A5 (enExample) | 2023-08-01 |
Family
ID=74659587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554990A Withdrawn JP2022543722A (ja) | 2019-08-16 | 2020-08-17 | 機能的ニューロン死に関連する神経系疾患の予防および／または治療におけるＰｔｂｐ１阻害剤の使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20220273726A1 (enExample) |
| EP (1) | EP4039801A4 (enExample) |
| JP (1) | JP2022543722A (enExample) |
| WO (2) | WO2021032069A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023150553A1 (en) * | 2022-02-01 | 2023-08-10 | University Of Rochester | Gpr17 promoter-based targeting and transduction of glial progenitor cells |
| US20240279654A1 (en) * | 2021-05-21 | 2024-08-22 | Ionis Pharmaceuticals, Inc. | Compounds for reducing ptbp1 expression |
| WO2023150557A1 (en) * | 2022-02-01 | 2023-08-10 | University Of Rochester | Methods of generating a population of neurons from human glial progenitor cells and genetic constructs for carrying out such methods |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| WO1991018088A1 (en) | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6989264B2 (en) | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| CA2379166C (en) | 1999-08-09 | 2013-03-26 | Targeted Genetics Corporation | Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| WO2008082730A2 (en) * | 2006-09-19 | 2008-07-10 | Novartis Ag | Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors |
| EP2104734A2 (en) * | 2006-12-08 | 2009-09-30 | Asuragen, INC. | Mir-20 regulated genes and pathways as targets for therapeutic intervention |
| US20100144838A1 (en) * | 2008-12-01 | 2010-06-10 | Beck William T | Methods for Identifying Modulators of Pyrimidine Tract Binding Protein |
| CN102858985A (zh) * | 2009-07-24 | 2013-01-02 | 西格马-奥尔德里奇有限责任公司 | 基因组编辑方法 |
| AU2011272941B2 (en) * | 2010-06-30 | 2014-05-29 | Compugen Ltd. | C10RF32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders |
| WO2014071157A1 (en) * | 2012-11-01 | 2014-05-08 | The Regents Of The University Of California | Methods for engineering non-neuronal cells into neurons and using newly engineered neurons to treat neurodegenerative diseases |
| US9481864B1 (en) * | 2015-06-30 | 2016-11-01 | University Of South Florida | Conversion of non-neuronal cells into neurons |
| CN105950557B (zh) * | 2016-04-22 | 2019-10-25 | 中国科学院生物物理研究所 | 一种控制人神经细胞重编程的信号通路及其应用 |
| WO2018048877A1 (en) * | 2016-09-06 | 2018-03-15 | The University Of North Carolina At Chapel Hill | Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cells |
| WO2018112446A2 (en) * | 2016-12-18 | 2018-06-21 | Selonterra, Inc. | Use of apoe4 motif-mediated genes for diagnosis and treatment of alzheimer's disease |
| JP2021520200A (ja) * | 2018-04-11 | 2021-08-19 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 非神経細胞のニューロンへの再プログラミング、及び神経変性疾患または障害を治療するための方法と組成物 |
| US12186353B2 (en) * | 2018-12-05 | 2025-01-07 | Adaerata, Limited Partnership | Method of reducing neuronal microtubule binding protein Tau (Tau) levels |
| CN109913420A (zh) * | 2019-03-07 | 2019-06-21 | 北京师范大学 | Cdc20共表达基因网络作为胶质瘤治疗靶点的应用 |
| CN109777877B (zh) * | 2019-03-19 | 2022-01-04 | 宁波市第一医院 | 基于ptbp1甲基化辅助诊断脑动脉瘤的检测试剂盒及其应用 |
-
2020
- 2020-08-17 EP EP20855397.4A patent/EP4039801A4/en not_active Withdrawn
- 2020-08-17 US US17/627,052 patent/US20220273726A1/en not_active Abandoned
- 2020-08-17 WO PCT/CN2020/109655 patent/WO2021032069A1/en not_active Ceased
- 2020-08-17 JP JP2021554990A patent/JP2022543722A/ja not_active Withdrawn
- 2020-08-17 WO PCT/CN2020/109653 patent/WO2021032068A1/zh not_active Ceased
-
2025
- 2025-07-18 US US19/273,720 patent/US20250345365A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Flaherty et al. | Neuronal impact of patient-specific aberrant NRXN1α splicing | |
| Tiedge et al. | Primary structure, neural-specific expression, and dendritic location of human BC200 RNA | |
| Zhang et al. | Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation | |
| JP2022543722A5 (enExample) | ||
| Hughes et al. | Identification of novel alternative splicing events in the huntingtin gene and assessment of the functional consequences using structural protein homology modelling | |
| Ryan et al. | Time-dependent changes in gene expression induced by secreted amyloid precursor protein-alpha in the rat hippocampus | |
| JP2021520200A5 (enExample) | ||
| CN105854017A (zh) | 一种治疗β-地中海贫血的试剂及其应用 | |
| Jinfeng et al. | The Effect of MSCs Derived from the Human Umbilical Cord Transduced by Fibroblast Growth Factor‐20 on Parkinson’s Disease | |
| Jaerve et al. | Age-dependent modulation of cortical transcriptomes in spinal cord injury and repair | |
| WO2024178223A1 (en) | Antisense oligonucleotides for preventing unc13a misplicing | |
| CN114555100A (zh) | 用于治疗阿尔兹海默症的组合物和方法 | |
| JP2020158456A (ja) | 神経軸索分岐異常の改善剤 | |
| Maurer et al. | Integral bHLH factor regulation of cell cycle exit and RGC differentiation | |
| CN114213518A (zh) | 调控糖脂代谢的Tmem52蛋白、编码基因、sgRNA及其应用 | |
| Traina et al. | Identification of differentially expressed genes induced in the rat brain by acetyl-L-carnitine as evidenced by suppression subtractive hybridisation | |
| Twine et al. | Sequencing of hippocampal and cerebellar transcriptomes provides new insights into the complexity of gene regulation in the human brain | |
| Markitantova et al. | Identification of the gene encoding nucleostemin in the eye tissues of Pleurodeles waltl | |
| Campbell et al. | Prediction of gene network models in limb muscle precursors | |
| Pai et al. | Assessment of the role of a functional VNTR polymorphism in MAOA gene promoter: a preliminary Study | |
| Hao et al. | Identification of a transient Sox5 expressing progenitor population in the neonatal ventral forebrain by a novel cis-regulatory element | |
| Dong et al. | Targeting pioneer transcription factor Ascl1 to promote optic nerve regeneration | |
| WO2020223303A1 (en) | Compositions and methods for increasing megakaryocyte production | |
| US20250297281A1 (en) | Compositions and methods for retinal neuron generation | |
| Barth et al. | Analysis of microRNA expression reveals convergent evolution of the molecular control of diapause in annual fish |